CTA-Sticky-button.png clinicaltrialsyearbook+button

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

octmidwest2017-header.jpg

Exploring the 2017 agenda highlights

With prevailing uncertainty as to the impact of changes to regulations and administration, this year’s event will offer attendees the opportunity to voice their concerns for the upcoming challenges.

Day 1 kicks off with a 20 minute spotlight presentation by the Global Contracts and Outsourcing Lead from Astellas, exploring the impact the 21st Century Cures Act will have on the biopharma industry. The ‘One-in-Two-Out’ rule will be addressed in this session. This will be followed by a Q&A session, allowing attendees to ask pressing questions.

The afternoon of day 2 will include an interactive session given by Theodore Danoff (Senior VP Clinical and Medical Affairs & Chief Medical Officer at Clarus Therapeutics). This interactive session will explore a novel idea for a future CRO selection tool. Theodore will firstly address the current challenges that are associated with vendor selection and he will ask the audience how they currently go about this.

He will then explore the idea of a CRO selection tool available online, similar to other online sites offering helpful feedback such as YELP.

Theodore is going to float this idea around and see what the audience thinks of it. The session will conclude with specific points to take away and how you can implement these ideas into your current process. This will be an excellent opportunity to explore a new, innovative idea and discuss its potential with fellow industry professionals.

Join us in Chicago in September 2017 for another exciting, collaborative OCT Midwest event!






CTSMD.jpg

300x250-Subscribe-for-updates-banner+version+2.jpg